The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / November / The Shift to Agile, Modular Manufacturing
Cell & Gene Biopharma Facilities & Equipment Bioprocessing Sponsored

The Shift to Agile, Modular Manufacturing

As industry conversations around manufacturing change, we caught up with Cytiva’s Joe Makowiecki to discuss modular and flexible solutions.

11/28/2025 0 min read Video

Sponsored By

Cytiva

Share

Take a look at the KUBio box trailer with Cytiva’s FlexFactory manufacturing solution that was on display at CPHI Frankfurt 2025!

“The shift towards personalized and advanced therapies, such as MRNA, viral vectors, and cell and gene therapies, has really redefined biomanufacturing, moving away from centralized large-scale facilities towards more agile, more modular environments,” says Joe Makowiecki, Enterprise Solutions Director of Product Management & Engineering at Cytiva.

Learn more about flexible manufacturing and Cytiva’s end-to-end offering in this video interview with Makowiecki.

He adds: “Cytiva delivers comprehensive support across the entire biomanufacturing lifecycle, from facility design and process development to equipment integration, automation, operator training and ongoing service. This holistic approach allows customers to focus on science; focus on their product pipeline and operations while Cytiva manages the infrastructure and complexity required to efficiently and compliantly bring manufacturing capacity online.”

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

The Manufacturing Questions Facing Chinese Biotech
Biopharma Business & Trends Technology & Manufacturing
The Manufacturing Questions Facing Chinese Biotech

September 9, 2026

5 min read

Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally

China’s Biopharma Homecoming
Biopharma Biopharma Regulation & Standards
China’s Biopharma Homecoming

September 1, 2026

7 min read

Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han

Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
Biopharma Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics

August 31, 2026

4 min read

New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products

The Hidden Complexity of Stability Storage
Biopharma Technology & Manufacturing
The Hidden Complexity of Stability Storage

August 27, 2026

9 min read

Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: